zirganpro.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /EPiServer/CMS/ Disallow: /Util/ Sitemap: https://www.zirganpro.com/sitemap.xml Sitemap: https://www.zirganpro.com/sitemap-video.xml # End robots.txt | ||
Meta Tags
| Title | ZIRGAN® (ganciclovir ophthalmic gel) 0.15%: Official HCP |
| Description | selectively and effectively target virus-infected Learn about Bausch + Lomb’s ZIRGAN® gel, a topical ophthalmic antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers). Find MOA, dosing information, prescription savings & |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 217.114.85.70 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
zirganpro.com Valuation
|
US$7,874,031
Last updated: 2022-06-23 05:47:44
zirganpro.com has Semrush global rank of 1,344,204. zirganpro.com has an estimated worth of US$ 7,874,031, based on its estimated Ads revenue. zirganpro.com receives approximately 908,542 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.70. According to SiteAdvisor, zirganpro.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$7,874,031 |
| Daily Ads Revenue | US$7,269 |
| Monthly Ads Revenue | US$218,051 |
| Yearly Ads Revenue | US$2,616,601 |
| Daily Unique Visitors | 60,570 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| zirganpro.com. | A | 7199 | IP: 217.114.85.70 |
| zirganpro.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| zirganpro.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| zirganpro.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| zirganpro.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| zirganpro.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| zirganpro.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| zirganpro.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
HtmlToTextCheckTime:2022-06-23 05:47:44
| Help your Eligible patients save bauschaccessprogram.com Share Savings Information FOR HEALTHCARE PROFESSIONALS ONLY Important Safety Information Prescribing Information Request Samples Patient Co-Pay Offer About Ocular HSV Mechanism of Action Dosing and Handling Savings and Formulary Savings and Support Formulary Lookup FOR HEALTHCARE PROFESSIONALS ONLY Important Safety Information Prescribing Information Request Samples Patient Co-Pay Offer selectively and effectively target virus-infected cells ZIRGAN is inactive in healthy corneal cells 1 In a clinical study, up to 77% of dendritic ulcers resolved at day 7 2,3* ZIRGAN is a topical antiviral agent that selectively targets HSV DNA synthesis in infected cells and is indicated for the treatment of acute herpetic keratitis (dendritic ulcers). 1,2 *Study design: 164 patients participated in a phase 3, open-label, randomized, controlled trial of ZIRGAN vs acyclovir (3%). Dosing was 5 times a day until the ulcer healed and then 3 times a |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: http://www.zirganpro.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 07:46:07 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 149 Connection: close Location: https://www.zirganpro.com/ X-Powered-By: ASP.NET Set-Cookie: ARRAffinity=53f4a96b1c4fe0ee3118f9ad5503cc06fc63377ccfde033e0776e5f7ac42f04d;Path=/;HttpOnly;Domain=www.zirganpro.com CF-Cache-Status: DYNAMIC Server: cloudflare CF-RAY: 6a3196ed2c0861c2-ORD HTTP/2 200 date: Sun, 24 Oct 2021 07:46:08 GMT content-type: text/html; charset=utf-8 cache-control: private vary: Accept-Encoding set-cookie: ASP.NET_SessionId=igknsn0qe223ewzqh3qykhde; path=/; HttpOnly; SameSite=Lax x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 request-context: appId=cid-v1:65ea7503-8884-4e73-918a-6c0534fd66d8 access-control-expose-headers: Request-Context x-powered-by: ASP.NET set-cookie: ARRAffinity=a02cb7c2a56d7c86ebdb40a44a5525635af57d2318fcc2c3896bd6e1c5e5c411;Path=/;HttpOnly;Secure;Domain=www.zirganpro.com set-cookie: ARRAffinitySameSite=a02cb7c2a56d7c86ebdb40a44a5525635af57d2318fcc2c3896bd6e1c5e5c411;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.zirganpro.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a3196ee0bd95c4f-STL |
zirganpro.com Whois Information
Domain Name: ZIRGANPRO.COM Registry Domain ID: 2330941653_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2019-10-09T09:34:51Z Creation Date: 2018-11-09T10:38:37Z Registry Expiry Date: 2021-11-09T10:38:37Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T15:36:41Z <<< |